MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with L

Lymecycline

Lymecycline 408mg capsules

Compatible

Stability notes for Lymecycline 408mg capsules

No stability data available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Tetralysal 300mg(408mg) capsules (Galderma (U.K.) Limited and Lymecycline 408mg Capsules (Morningside Healthcare Ltd).

Suppliers (12) of Lymecycline 408mg capsules
Lymecycline 408mg capsules (A A H Pharmaceuticals Ltd)
Lymecycline 408mg capsules (AAH Hillcross)
Lymecycline 408mg capsules (Accord-UK Ltd)
Lymecycline 408mg capsules (Alliance Healthcare (Distribution) Ltd)
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd)
Lymecycline 408mg capsules (Medihealth (Northern) Ltd)
Lymecycline 408mg capsules (Morningside Healthcare Ltd)
Lymecycline 408mg capsules (Sigma Pharmaceuticals Plc)
Lymecycline 408mg capsules (Somex Pharma)
Lymecycline 408mg capsules (Teva UK Ltd)
Tetralysal 300 capsules (Galderma (UK) Ltd)
Tetralysal 300 capsules (Necessity Supplies Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.